To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MAP3K2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
411 supporting clones for gene MAP3K2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AF111105   .a 1 to 2135 1 to 2130 V103L D198E D225G Q275K E276D ... tiling clone,   2133/2133
(100 %)
32 diff
(98.5 %id)
BC136293 Testicle, PCR rescued clones .a 32 to 3197 1 to 3162 exact tiling clone,   3162/3162
(100 %)
6 diff
(99.9 %id)
AF239798   .a 70 to 2073 1 to 2003 V103L D198E T293N S294Q R296T ...     2003/2003
(100 %)
10 diff
(99.6 %id)
AK315007 trachea .b 1 to 2143 2 to 2145 R151T L152A S153I I154Y I155N ... tiling clone,   2145/2145
(100 %)
3 diff
(99.9 %id)
DB225897 trachea .b 1 to 563 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
TI_1971555263   .b 211 to 1368 63 to 1213     Submitted on the opposite strand 1151/1314
(87 %)
22 diff
(98.4 %id)
TI_1971559245   .b 211 to 1295 59 to 1141     Submitted on the opposite strand 1083/1238
(87 %)
10 diff
(99.2 %id)
TI_1971559569   .b 211 to 1271 123 to 1171     Submitted on the opposite strand 1049/1288
(81 %)
23 diff
(98.3 %id)
NM_006609.3   .b 219 to 5159 1 to 4941 exact RefSeq,   4941/4941
(100 %)
0 diff
(100 %id)
AB208963 brain .b 287 to 3775 10 to 3492   tiling clone,   3483/3492
(99 %)
10 diff
(99.8 %id)
BP353858   .b 321 to 901 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BU160514 melanotic melanoma, skin .b 344 to 1185 12 to 855       844/855
(98 %)
9 diff
(99.0 %id)
BP199086 brain .b 361 to 952 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
TI_1971559565   .b 583 to 1745 1 to 1151       1151/1282
(89 %)
31 diff
(97.6 %id)
BF981564 duodenal adenocarcinoma, cell line, small intestine .b 611 to 1270 1 to 668       668/990
(67 %)
32 diff
(96.8 %id)
CN354491 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 708 to 1137 1 to 430       430/430
(100 %)
0 diff
(100 %id)
BP334092 salivary gland .b 710 to 1293 1 to 584       584/584
(100 %)
10 diff
(98.3 %id)
AK075004   .b 820 to 3775 1 to 2956   tiling clone, available from FLJ,   2956/2956
(100 %)
2 diff
(100.0 %id)
DA737230   .b 821 to 1647 2 to 827   capped   826/826
(100 %)
3 diff
(99.7 %id)
AA456858 germinal center B cell .b 881 to 1149 270 to 1     Submitted on the opposite strand 270/291
(92 %)
2 diff
(99.4 %id)
AA311403   .b 930 to 1402 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
BX641216   .b 1170 to 1805 1 to 637       637/637
(100 %)
4 diff
(99.4 %id)
BP243860 Liver .b 1482 to 2046 1 to 567       567/567
(100 %)
8 diff
(98.6 %id)
AW957369   .b 1487 to 2116 10 to 639       630/640
(98 %)
7 diff
(99.0 %id)
AA297775 brain .b 1488 to 1803 1 to 316       316/316
(100 %)
2 diff
(99.4 %id)
BC065755 Brain, primitive neuroectodermal .b 1651 to 3060 1 to 1406   available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1406/1406
(100 %)
5 diff
(99.7 %id)
BF700349 brain, primitive neuroectoderm .b 1654 to 2214 1 to 573   available from MGC,   573/851
(67 %)
32 diff
(96.3 %id)
AK027345 whole embryo, mainly body .b 1708 to 3520 1 to 1808   available from FLJ,   1808/1808
(100 %)
6 diff
(99.7 %id)
DA572222 whole embryo, mainly body .b 1709 to 2516 2 to 810   capped   809/810
(99 %)
7 diff
(99.2 %id)
CN354489 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1741 to 2211 1 to 473       473/473
(100 %)
6 diff
(98.8 %id)
CB269343 adipose .b 1788 to 2387 1 to 600       600/600
(100 %)
3 diff
(99.5 %id)
AI472964 pooled .b 1901 to 2403 521 to 21   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 501/501
(100 %)
7 diff
(98.7 %id)
TI_1971559567   .b 1914 to 3072 12 to 1161       1150/1342
(85 %)
15 diff
(98.9 %id)
EC568555 Prostate .b 2006 to 2103 1 to 100       100/100
(100 %)
1 diff
(99.0 %id)
AW450415   .b 2013 to 2537 525 to 1       525/525
(100 %)
0 diff
(100 %id)
FN060553 breast carcinoma .b 2051 to 2123 1 to 73       73/73
(100 %)
3 diff
(95.9 %id)
FN153100 breast carcinoma .b 2078 to 2172 1 to 98       98/98
(100 %)
3 diff
(97.0 %id)
CN354490 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2139 to 2471 8 to 340       333/340
(97 %)
6 diff
(98.3 %id)
BE539459 cervix .b 2262 to 2893 1 to 641       641/803
(79 %)
20 diff
(97.6 %id)
TI_1971557929   .b 2359 to 3385 1263 to 254       1010/1332
(75 %)
0 diff
(100 %id)
BG898746 cartilage .b 2365 to 2962 88 to 685       598/620
(96 %)
6 diff
(99.1 %id)
BE568205 bladder, carcinoma, cell line .b 2446 to 3037 1 to 585       585/679
(86 %)
25 diff
(96.4 %id)
AJ705963 bone marrow .b 2448 to 2846 14 to 412       399/412
(96 %)
6 diff
(98.6 %id)
FN132897 breast carcinoma .b 2456 to 2518 68 to 4     Submitted on the opposite strand 65/68
(95 %)
0 diff
(100 %id)
BF576270 muscle (skeletal) .b 2457 to 3147 1 to 690       690/690
(100 %)
58 diff
(91.6 %id)
DW451635 Liver .b 2471 to 2833 14 to 376       363/376
(96 %)
6 diff
(98.5 %id)
DW459420 Liver .b 2471 to 2605 14 to 148       135/148
(91 %)
6 diff
(96.0 %id)
TI_1971558185   .b 2504 to 3385 1123 to 252       872/1323
(65 %)
0 diff
(100 %id)
BE256459 eye, retinoblastoma .b 2505 to 3168 1 to 657       657/698
(94 %)
18 diff
(97.5 %id)
FN159267 breast carcinoma .b 2514 to 2634 118 to 1     Submitted on the opposite strand 118/118
(100 %)
4 diff
(96.7 %id)
TI_1971558167   .b 2520 to 3385 1099 to 251       849/1271
(66 %)
0 diff
(100 %id)
BG925046 cartilage .b 2531 to 3151 79 to 694       616/633
(97 %)
8 diff
(98.8 %id)
AW296520   .b 2547 to 3004 1 to 454     Submitted on the opposite strand 454/454
(100 %)
12 diff
(97.4 %id)
CB070122 Pancreas, Purified pancreatic islet .b 2593 to 3188 1 to 596       596/596
(100 %)
0 diff
(100 %id)
CA773950 Pancreas, Purified pancreatic islet .b 2644 to 3262 1 to 617   fully sequenced,   617/617
(100 %)
3 diff
(99.6 %id)
BF528673 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2722 to 3528 1 to 794       794/901
(88 %)
33 diff
(96.4 %id)
BP327599 prostata .b 2729 to 3317 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BM699354 eye, fetal eyes .b 2755 to 3123 1 to 367     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 367/367
(100 %)
1 diff
(99.8 %id)
BE925746 amnion_normal .b 2765 to 3094 10 to 329       320/329
(97 %)
6 diff
(98.2 %id)
BX116535   .b 2782 to 3295 1 to 512       512/512
(100 %)
2 diff
(99.7 %id)
AA448115   .b 2782 to 3211 1 to 428       428/428
(100 %)
1 diff
(99.8 %id)
W69594 heart .b 2801 to 3257 1 to 453       453/455
(99 %)
5 diff
(99.0 %id)
BG181106 adenocarcinoma, cell line, Prostate .b 2866 to 3564 1 to 705       705/837
(84 %)
15 diff
(98.3 %id)
BM461929 leiomyosarcoma, uterus .b 2868 to 3747 25 to 911       887/911
(97 %)
6 diff
(99.4 %id)
AA373816 lung .b 2877 to 3186 1 to 310       310/314
(98 %)
1 diff
(99.7 %id)
AW957499   .b 2878 to 3411 1 to 534       534/535
(99 %)
4 diff
(99.3 %id)
FN079713 breast carcinoma .b 2881 to 2982 1 to 102       102/103
(99 %)
2 diff
(98.1 %id)
N31338 melanocyte .b 2902 to 3379 1 to 480   fully sequenced,   480/480
(100 %)
3 diff
(99.4 %id)
DW415917 Liver .b 2953 to 3247 17 to 311       295/311
(94 %)
6 diff
(98.1 %id)
FN098462 breast carcinoma .b 2960 to 3088 130 to 1     Submitted on the opposite strand 130/130
(100 %)
3 diff
(97.7 %id)
TI_149273013   .b 2981 to 3775 881 to 93   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 789/833
(94 %)
28 diff
(96.7 %id)
DB359213 whole embryo, mainly body .b 2990 to 3520 526 to 1       526/526
(100 %)
16 diff
(97.0 %id)
TI_1971559563   .b 2999 to 3385 1 to 387       387/1278
(30 %)
5 diff
(99.7 %id)
TI_154110907   .b 3035 to 3775 807 to 79   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 729/799
(91 %)
37 diff
(95.4 %id)
BU619722 Cell Line, Chondrosarcoma .b 3043 to 3791 748 to 1   tiling clone,   748/748
(100 %)
4 diff
(99.5 %id)
CA502933 Human Lung Epithelial cells, lung .b 3054 to 3775 740 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 722/722
(100 %)
2 diff
(99.8 %id)
R91266 liver and spleen .b 3085 to 3485 1 to 409   fully sequenced,   409/409
(100 %)
6 diff
(98.6 %id)
AV718868 corresponding non cancerous liver tissue .b 3087 to 3761 671 to 1     Submitted on the opposite strand 671/671
(100 %)
35 diff
(94.8 %id)
DB636694 testis .b 3087 to 3770 1 to 683     Submitted on the opposite strand 683/687
(99 %)
9 diff
(98.7 %id)
DW459296 Liver .b 3095 to 3227 17 to 149       133/149
(89 %)
11 diff
(92.7 %id)
FN082174 breast carcinoma .b 3102 to 3160 1 to 58       58/59
(98 %)
2 diff
(96.7 %id)
BQ015887 lung, Metastatic Chondrosarcoma .b 3131 to 3775 660 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 643/643
(100 %)
4 diff
(99.4 %id)
CB160050 Liver .b 3159 to 3675 1 to 517       517/517
(100 %)
2 diff
(99.7 %id)
CB143714 Liver .b 3189 to 3590 402 to 1     Submitted on the opposite strand 402/402
(100 %)
1 diff
(99.8 %id)
DB369813   .b 3196 to 3775 580 to 1       580/583
(99 %)
9 diff
(98.5 %id)
BP315325 mammary gland .b 3199 to 3781 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
AI125541   .b 3204 to 3778 575 to 1       575/575
(100 %)
0 diff
(100 %id)
BU675482 lung, Primary Lung Epithelial Cells .b 3225 to 3775 569 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 551/551
(100 %)
2 diff
(99.7 %id)
AW295443   .b 3227 to 3775 566 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 549/549
(100 %)
2 diff
(99.7 %id)
BU069223 Pancreas, Purified pancreatic islet .b 3232 to 3774 543 to 1   fully sequenced,   543/543
(100 %)
1 diff
(99.9 %id)
BQ010383 Chondrosarcoma, Left Pubic Bone .b 3233 to 3775 561 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 543/543
(100 %)
3 diff
(99.5 %id)
FN054746 breast carcinoma .b 3240 to 3291 51 to 1     Submitted on the opposite strand 51/52
(98 %)
1 diff
(98.1 %id)
AI989947 pooled germ cell tumors .b 3241 to 3775 533 to 1       533/533
(100 %)
2 diff
(99.7 %id)
BM670012 eye, fetal eyes .b 3243 to 3775 551 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 533/533
(100 %)
2 diff
(99.7 %id)
BE046999 pooled germ cell tumors .b 3258 to 3776 518 to 1       518/518
(100 %)
2 diff
(99.7 %id)
AA779242 liver and spleen .b 3270 to 3774 505 to 1       505/505
(100 %)
1 diff
(99.9 %id)
AW236213 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .b 3276 to 3775 500 to 1       500/500
(100 %)
3 diff
(99.4 %id)
BE674435 carcinoid, lung .b 3283 to 3779 497 to 1       497/497
(100 %)
1 diff
(99.8 %id)
AA455446 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3298 to 3635 1 to 338       338/338
(100 %)
1 diff
(99.8 %id)
AI167630 pooled .b 3299 to 3781 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
AA836223 germinal center B cell .b 3304 to 3784 480 to 1       480/480
(100 %)
4 diff
(99.2 %id)
CA448247 Chondrosarcoma, Left Pubic Bone .b 3310 to 3775 483 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 465/465
(100 %)
3 diff
(99.4 %id)
AW664585 2 pooled high-grade transitional celltumors, genitourinary tract .b 3313 to 3784 472 to 1       472/472
(100 %)
3 diff
(99.4 %id)
AI272813 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3315 to 3773 460 to 2       459/460
(99 %)
0 diff
(100 %id)
AI218709 pooled .b 3316 to 3774 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
AW182927 pooled .b 3320 to 3775 456 to 1       456/456
(100 %)
0 diff
(100 %id)
R67910 placenta .b 3323 to 3774 458 to 1       458/459
(99 %)
18 diff
(96.1 %id)
AI808747 pooled .b 3328 to 3775 447 to 1       447/449
(99 %)
7 diff
(98.5 %id)
AA811816 germinal center B cell .b 3329 to 3784 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
AI934917 2 pooled tumors (clear cell type), Kidney .b 3334 to 3777 443 to 1       443/443
(100 %)
6 diff
(98.7 %id)
AI367441 2 pooled tumors (clear cell type), Kidney .b 3335 to 3784 450 to 1       450/450
(100 %)
4 diff
(99.2 %id)
AI679378 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3339 to 3775 436 to 1       436/436
(100 %)
3 diff
(99.4 %id)
AI679887 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3340 to 3775 435 to 1       435/435
(100 %)
3 diff
(99.4 %id)
AW003822 pooled germ cell tumors .b 3341 to 3775 433 to 1       433/433
(100 %)
2 diff
(99.6 %id)
AI199969 lung .b 3342 to 3785 442 to 1       442/442
(100 %)
3 diff
(99.4 %id)
AA447971   .b 3343 to 3779 437 to 1       437/437
(100 %)
2 diff
(99.6 %id)
N21384 melanocyte .b 3349 to 3774 428 to 1   fully sequenced,   428/428
(100 %)
6 diff
(98.6 %id)
N26277 melanocyte .b 3349 to 3775 429 to 1       429/430
(99 %)
5 diff
(98.9 %id)
AI075191 liver and spleen .b 3351 to 3785 435 to 1       435/435
(100 %)
3 diff
(99.4 %id)
AA004820 liver and spleen .b 3354 to 3775 424 to 1       424/424
(100 %)
3 diff
(99.3 %id)
AI355336 lung .b 3355 to 3774 420 to 1       420/420
(100 %)
0 diff
(100 %id)
BE245813 leukopheresis .b 3370 to 3737 1 to 369       369/373
(98 %)
7 diff
(98.2 %id)
AI400127 pooled .b 3373 to 3780 408 to 1       408/408
(100 %)
0 diff
(100 %id)
BE672123 pooled germ cell tumors .b 3374 to 3775 402 to 1       402/402
(100 %)
4 diff
(99.1 %id)
AA927143 pooled .b 3381 to 3775 394 to 1       394/398
(98 %)
1 diff
(99.8 %id)
AI627481 Kidney .b 3381 to 3775 395 to 1       395/395
(100 %)
0 diff
(100 %id)
FN098687 breast carcinoma .b 3422 to 3529 1 to 104       104/104
(100 %)
4 diff
(96.2 %id)
AA761855 germinal center B cell .b 3423 to 3784 362 to 1       362/362
(100 %)
2 diff
(99.5 %id)
AA640518   .b 3429 to 3790 371 to 9       363/371
(97 %)
0 diff
(100 %id)
AI219952 pooled .b 3433 to 3775 343 to 1       343/343
(100 %)
0 diff
(100 %id)
AI698552 pooled .b 3438 to 3775 342 to 1       342/342
(100 %)
4 diff
(98.9 %id)
DW426628 Liver .b 3440 to 3704 17 to 281       265/281
(94 %)
6 diff
(97.9 %id)
DW460433 Liver .b 3440 to 3561 17 to 138       122/138
(88 %)
6 diff
(95.7 %id)
AW850061 colon .b 3455 to 3728 1 to 274       274/274
(100 %)
0 diff
(100 %id)
R91267 liver and spleen .b 3455 to 3775 324 to 1   fully sequenced,   324/324
(100 %)
6 diff
(98.2 %id)
W69408 heart .b 3463 to 3775 313 to 1       313/313
(100 %)
3 diff
(99.1 %id)
CB069008 Pancreas, Purified pancreatic islet .b 3472 to 3775 1 to 303   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 303/303
(100 %)
2 diff
(99.4 %id)
CK904738 Islets of Langerhans, Pancreas .b 3490 to 3775 1 to 286   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 286/286
(100 %)
0 diff
(100 %id)
FN077466 breast carcinoma .b 3495 to 3595 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
BM069841 Islets of Langerhans, Pancreas .b 3506 to 3779 1 to 274   fully sequenced,   274/274
(100 %)
0 diff
(100 %id)
BM069754 Islets of Langerhans, Pancreas .b 3506 to 3779 1 to 274       274/274
(100 %)
4 diff
(98.6 %id)
CK904737 Islets of Langerhans, Pancreas .b 3507 to 3775 269 to 1       269/269
(100 %)
3 diff
(98.9 %id)
AA860134   .b 3510 to 3778 269 to 1       269/269
(100 %)
0 diff
(100 %id)
AA350443 brain .b 3519 to 3775 257 to 1       257/257
(100 %)
2 diff
(99.3 %id)
AI813319 2 pooled tumors (clear cell type), Kidney .b 3524 to 3778 255 to 1       255/255
(100 %)
0 diff
(100 %id)
AI587528 adenocarcinoma, Pancreas .b 3525 to 3775 251 to 1       251/251
(100 %)
0 diff
(100 %id)
BM069520 Islets of Langerhans, Pancreas .b 3536 to 3775 240 to 1       240/240
(100 %)
1 diff
(99.6 %id)
FN176525 breast carcinoma .b 3540 to 3636 96 to 1     Submitted on the opposite strand 96/99
(96 %)
1 diff
(99.0 %id)
FN146448 breast carcinoma .b 3547 to 3619 74 to 1     Submitted on the opposite strand 74/75
(98 %)
1 diff
(98.7 %id)
AW612171 carcinoid, lung .b 3551 to 3774 224 to 1       224/224
(100 %)
0 diff
(100 %id)
FN048521 breast carcinoma .b 3576 to 3649 72 to 1     Submitted on the opposite strand 72/75
(96 %)
2 diff
(97.4 %id)
DW454801 Liver .b 3581 to 3742 17 to 178       162/178
(91 %)
6 diff
(96.7 %id)
CB068847 Pancreas, Purified pancreatic islet .b 3615 to 3774 160 to 1   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 160/160
(100 %)
0 diff
(100 %id)
FN104717 breast carcinoma .b 3627 to 3689 1 to 64       64/65
(98 %)
2 diff
(97.0 %id)
BM069595 Islets of Langerhans, Pancreas .b 3643 to 3775 133 to 1   fully sequenced,   133/133
(100 %)
0 diff
(100 %id)
FN083222 breast carcinoma .b 3704 to 3773 70 to 2     Submitted on the opposite strand 69/70
(98 %)
0 diff
(100 %id)
BQ423724 embryonal carcinoma, cell line, testis .b 3706 to 4506 1 to 806   tiling clone,   806/915
(88 %)
14 diff
(98.5 %id)
W07290.
matches multiple genes
lung .b 3780 to 4306 1 to 533     also hits gene PDE5A 533/537
(99 %)
18 diff
(96.7 %id)
AK074577 whole embryo, mainly head .b 3796 to 4999 1 to 1205   tiling clone, available from FLJ,   1205/1789
(67 %)
6 diff
(99.7 %id)
DA571050 whole embryo, mainly head .b 3797 to 4537 2 to 742   capped   741/752
(98 %)
1 diff
(99.9 %id)
AL121515 melanoma (MeWo cell line) .b 3800 to 4388 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
CD675846 eye, lens .b 3803 to 4318 10 to 525       516/525
(98 %)
6 diff
(98.9 %id)
W19540.
matches multiple genes
parathyroid gland, parathyroid tumor .b 3804 to 4352 1 to 551     also hits gene riyayo 551/551
(100 %)
4 diff
(99.3 %id)
CF139004 CNCAP(3)T-225 cell line, Prostate .b 3815 to 4307 1 to 493       493/493
(100 %)
4 diff
(99.2 %id)
TI_154169200   .b 3822 to 4327 80 to 585       506/506
(100 %)
0 diff
(100 %id)
BQ226788 embryonal carcinoma, cell line, testis .b 3829 to 4584 1 to 773       773/913
(84 %)
28 diff
(97.0 %id)
BM475800 embryonal carcinoma, cell line, testis .b 3887 to 4912 54 to 1083       1030/1088
(94 %)
30 diff
(97.3 %id)
BE541249 cervix .b 3894 to 4644 1 to 753       753/916
(82 %)
29 diff
(96.9 %id)
DA673701   .b 4043 to 4617 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BF978848 melanotic melanoma, high MDR, skin .b 4115 to 4821 1 to 704       704/857
(82 %)
23 diff
(97.4 %id)
BF791139 muscle (skeletal) .b 4132 to 4853 1 to 712       712/822
(86 %)
28 diff
(96.6 %id)
BF244603 brain, glioblastoma .b 4151 to 4674 1 to 525       525/1210
(43 %)
7 diff
(99.5 %id)
FN106376 breast carcinoma .b 4242 to 4295 1 to 54       54/54
(100 %)
0 diff
(100 %id)
AW452699   .b 4247 to 4706 477 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 460/463
(99 %)
0 diff
(100 %id)
BM685911 eye, Retina Foveal and Macular .b 4330 to 4543 1 to 216   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 216/216
(100 %)
6 diff
(97.3 %id)
AI474330 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4426 to 4891 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BF694810 muscle (skeletal) .b 4456 to 4997 1 to 543       543/543
(100 %)
5 diff
(99.1 %id)
AW452085   .b 4470 to 4693 236 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 224/227
(98 %)
4 diff
(98.3 %id)
BU726273 eye, Retina Foveal and Macular .b 4513 to 4891 396 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 379/379
(100 %)
2 diff
(99.5 %id)
BM470563 leiomyosarcoma, uterus .b 4514 to 5390 14 to 905       892/1084
(82 %)
46 diff
(95.8 %id)
CB142693 Liver .b 4518 to 5159 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
BE003065 breast_normal .b 4572 to 4940 387 to 19     Submitted on the opposite strand 369/387
(95 %)
0 diff
(100 %id)
DA713397   .b 4639 to 5219 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
FN135532 breast carcinoma .b 4663 to 4778 109 to 1     Submitted on the opposite strand 109/111
(98 %)
9 diff
(91.9 %id)
BQ370561 placenta_normal .b 4698 to 5140 451 to 9       443/451
(98 %)
0 diff
(100 %id)
BQ010212 Chondrosarcoma, Left Pubic Bone .b 4737 to 5383 655 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 645/645
(100 %)
2 diff
(99.7 %id)
BM995158 Chondrosarcoma, Left Pubic Bone .b 4748 to 5384 655 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 637/637
(100 %)
2 diff
(99.7 %id)
BF669107 brain, primitive neuroectoderm .b 4757 to 5359 1 to 593       593/846
(70 %)
19 diff
(97.8 %id)
BX643897   .b 4831 to 5641 1 to 810       810/810
(100 %)
5 diff
(99.4 %id)
AW816663 stomach .b 4858 to 5112 254 to 1       254/254
(100 %)
4 diff
(98.5 %id)
N75806.
matches multiple genes
lung .b 4924 to 5384 466 to 1     also hits gene PDE5A 466/470
(99 %)
2 diff
(99.6 %id)
AW840157 leiomios .b 4940 to 5107 179 to 8       172/189
(91 %)
0 diff
(100 %id)
AA621274   .b 4944 to 5378 435 to 1       435/435
(100 %)
2 diff
(99.6 %id)
BX116493 adenocarcinoma, Pancreas .b 4946 to 5375 444 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 430/434
(99 %)
1 diff
(99.8 %id)
AA634530   .b 4983 to 5377 395 to 1       395/395
(100 %)
3 diff
(99.3 %id)
N95050 parathyroid gland, parathyroid tumor .b 4996 to 5388 396 to 7       390/396
(98 %)
0 diff
(100 %id)
FN079346 breast carcinoma .b 5012 to 5116 1 to 100       100/101
(99 %)
6 diff
(94.1 %id)
BM996020 lung, Metastatic Chondrosarcoma .b 5048 to 5638 609 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 591/591
(100 %)
3 diff
(99.5 %id)
AA971079 pooled .b 5049 to 5384 350 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 335/335
(100 %)
3 diff
(99.2 %id)
AI251000 adenocarcinoma, Pancreas .b 5110 to 5376 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
AW206683   .b 5112 to 5375 281 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 264/274
(96 %)
0 diff
(100 %id)
AW856256 colon .b 5167 to 5288 8 to 131       124/131
(94 %)
6 diff
(95.5 %id)
BE542214 cervix .b 5254 to 5948 1 to 688       688/828
(83 %)
14 diff
(98.4 %id)
CN282092 embryonic stem cells, cell lines H1, H7, andH9 .b 5323 to 5936 616 to 3   tiling clone, Submitted on the opposite strand 614/616
(99 %)
0 diff
(100 %id)
BF755955 colon .b 5565 to 5830 1 to 264       264/268
(98 %)
10 diff
(96.3 %id)
CB051887 leiomyosarcoma, soft tissue .b 5616 to 6017 9 to 410     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 402/410
(98 %)
6 diff
(98.6 %id)
AW503983 lymph .b 5758 to 6295 1 to 538       538/538
(100 %)
6 diff
(98.9 %id)
TI_154160068   .b 5765 to 6316 87 to 637       551/551
(100 %)
2 diff
(99.7 %id)
BG502520 embryonal carcinoma, testis .b 5890 to 6530 1 to 641       641/643
(99 %)
30 diff
(95.4 %id)
BG504375 embryonal carcinoma, testis .b 5890 to 6506 1 to 620       620/621
(99 %)
19 diff
(97.0 %id)
BG613148 embryonal carcinoma, testis .b 5890 to 6786 1 to 896   tiling clone,   896/952
(94 %)
46 diff
(95.2 %id)
AI684111 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 6106 to 6638 531 to 1       531/531
(100 %)
1 diff
(99.9 %id)
CB051644 leiomyosarcoma, soft tissue .b 6171 to 6844 701 to 28   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 674/674
(100 %)
0 diff
(100 %id)
AW970837   .b 6283 to 6723 440 to 1     Submitted on the opposite strand 440/442
(99 %)
5 diff
(98.9 %id)
AA897419 pooled .b 6297 to 6725 431 to 3       429/431
(99 %)
0 diff
(100 %id)
AI283495 pooled .b 6307 to 6725 420 to 3       418/420
(99 %)
0 diff
(100 %id)
AA574133 colon .b 6308 to 6724 427 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 416/416
(100 %)
2 diff
(99.6 %id)
AA824402   .b 6322 to 6725 406 to 3       404/406
(99 %)
0 diff
(100 %id)
AL704819 human skeletal muscle .b 6369 to 6827 7 to 466       460/466
(98 %)
6 diff
(98.8 %id)
TI_149280064   .b 6369 to 6841 79 to 551     Submitted on the opposite strand 473/881
(53 %)
14 diff
(98.5 %id)
BU678938 lung, Primary Lung Epithelial Cells .b 6378 to 6813 1 to 436     Submitted on the opposite strand 436/436
(100 %)
6 diff
(98.7 %id)
CB051886 leiomyosarcoma, soft tissue .b 6384 to 6844 493 to 32   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 462/462
(100 %)
3 diff
(99.4 %id)
BE674399 carcinoid, lung .b 6392 to 6837 1 to 446     Submitted on the opposite strand 446/446
(100 %)
3 diff
(99.4 %id)
BF432909 carcinoid, lung .b 6392 to 6899 1 to 508     Submitted on the opposite strand 508/508
(100 %)
4 diff
(99.3 %id)
AI264675 Kidney .b 6396 to 6865 470 to 1       470/472
(99 %)
0 diff
(100 %id)
M62037   .b 6401 to 6673 1 to 273       273/273
(100 %)
0 diff
(100 %id)
AA884716 pooled .b 6413 to 6820 408 to 1       408/408
(100 %)
2 diff
(99.6 %id)
AA918438 pooled .b 6463 to 6725 265 to 3       263/265
(99 %)
0 diff
(100 %id)
AA768447 germinal center B cell .b 6475 to 6827 355 to 3       353/355
(99 %)
0 diff
(100 %id)
AI419778 pooled .b 6512 to 6820 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
AI572962 lymph node, lymphoma, follicular mixed small and largecell .b 6533 to 6724 216 to 25   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 192/192
(100 %)
2 diff
(99.0 %id)
DB275830 uterus .b 6537 to 7105 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
GD155643   .b 6553 to 6753 210 to 9   AAA Submitted on the opposite strand 202/212
(95 %)
0 diff
(100 %id)
AA757873 pineal gland .b 6576 to 6796 221 to 1       221/221
(100 %)
0 diff
(100 %id)
DA619043   .b 6596 to 7146 2 to 552   tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AW501318 lymph .b 6689 to 7097 8 to 412       405/412
(98 %)
6 diff
(98.6 %id)
TI_154156087   .b 6689 to 7188 80 to 575       496/497
(99 %)
10 diff
(98.0 %id)
TI_154156091   .b 6689 to 7189 80 to 578       499/499
(100 %)
34 diff
(93.2 %id)
TI_154156093   .b 6697 to 7188 83 to 569       487/496
(98 %)
19 diff
(96.2 %id)
AW501325 lymph .b 6698 to 7034 1 to 333       333/333
(100 %)
5 diff
(98.5 %id)
BF338081 brain, glioblastoma with EGFR amplification .b 6785 to 7471 1 to 682       682/753
(90 %)
17 diff
(97.8 %id)
BI909002 leukocyte .b 6876 to 7553 1 to 680       680/680
(100 %)
20 diff
(97.1 %id)
TI_57237362   .b 6876 to 7553 38 to 717       680/717
(94 %)
8 diff
(98.9 %id)
TI_57237425   .b 6876 to 7435 30 to 600       571/1166
(48 %)
34 diff
(97.1 %id)
BI909210 leukocyte .b 6877 to 7435 1 to 570       570/1136
(50 %)
34 diff
(97.1 %id)
H70423 liver and spleen .b 7019 to 7379 1 to 363       363/363
(100 %)
7 diff
(98.1 %id)
CX785360 human embryonic stem cells .b 7054 to 7831 1 to 777   tiling clone,   777/777
(100 %)
1 diff
(99.9 %id)
BE893823 melanotic melanoma, skin .b 7170 to 7756 1 to 586       586/589
(99 %)
5 diff
(99.2 %id)
CB999005 Pooled-Skin .b 7254 to 7943 1 to 707       707/882
(80 %)
28 diff
(96.9 %id)
BX499708 Liver .b 7314 to 7903 1 to 590       590/590
(100 %)
6 diff
(99.0 %id)
AA132650 colon, tumor .b 7331 to 7728 1 to 399       399/401
(99 %)
2 diff
(99.6 %id)
BE892693 melanotic melanoma, skin .b 7404 to 8085 1 to 682       682/682
(100 %)
5 diff
(99.3 %id)
CR743851   .b 7535 to 8043 1 to 509       509/509
(100 %)
3 diff
(99.5 %id)
DB281334 uterus .b 7636 to 8173 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
AA737471 germinal center B cell .b 7643 to 7931 289 to 1       289/289
(100 %)
0 diff
(100 %id)
BU161848 melanotic melanoma, skin .b 7709 to 8473 1 to 771   tiling clone,   771/835
(92 %)
15 diff
(98.3 %id)
DB223685 trachea .b 7736 to 8292 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
FN124181 breast carcinoma .b 7860 to 7926 1 to 67       67/67
(100 %)
6 diff
(91.1 %id)
AL600323   .b 7989 to 8460 21 to 492       472/492
(95 %)
6 diff
(98.8 %id)
DA024305   .b 8087 to 8647 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BQ313959 breast_normal .b 8107 to 8445 34 to 370       337/370
(91 %)
6 diff
(98.4 %id)
BG432893 Kidney .b 8115 to 8913 1 to 791   tiling clone,   791/791
(100 %)
28 diff
(96.5 %id)
BU941807 mixed (pool of 40 RNAs) .b 8118 to 8881 1 to 765   tiling clone,   765/770
(99 %)
9 diff
(98.9 %id)
DA151936 amygdala .b 8121 to 8692 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AK093893 trachea .b 9103 to 11053 1 to 1952   tiling clone, available from FLJ,   1952/1952
(100 %)
3 diff
(99.9 %id)
DB202295 trachea .b 9104 to 9688 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA902112   .b 9131 to 9696 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA040161 bladder .b 9145 to 9474 2 to 331   capped   330/330
(100 %)
0 diff
(100 %id)
DA360865 subthalamic nucleus .b 9149 to 9694 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
EH327060   .b 9173 to 9252 1 to 80       80/80
(100 %)
0 diff
(100 %id)
DA268223 caudate nucleus .b 9233 to 9799 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
FN054896 breast carcinoma .b 9268 to 9328 67 to 6     Submitted on the opposite strand 62/68
(91 %)
0 diff
(100 %id)
BY996685   .b 9292 to 9955 3 to 668       666/668
(99 %)
6 diff
(99.2 %id)
BX483495   .b 9398 to 9849 1 to 455       455/455
(100 %)
2 diff
(99.6 %id)
BU929945 placenta .b 9505 to 10187 1 to 691       691/729
(94 %)
13 diff
(98.3 %id)
AA243280 germinal center B cell .b 9548 to 9974 1 to 429       429/429
(100 %)
1 diff
(99.8 %id)
BI466975 Pancreas, Purified pancreatic islet .b 9576 to 9966 11 to 403       393/403
(97 %)
6 diff
(98.6 %id)
CA942523 Pancreas, Purified pancreatic islet .b 9586 to 10207 1 to 624       624/624
(100 %)
1 diff
(99.9 %id)
BU951735 Pancreas, Purified pancreatic islet .b 9846 to 10325 1 to 480       480/480
(100 %)
5 diff
(99.0 %id)
AA476361   .b 9911 to 10270 1 to 360       360/360
(100 %)
0 diff
(100 %id)
BG545910 lung .b 9940 to 10662 1 to 738       738/800
(92 %)
26 diff
(96.8 %id)
C15291   .b 9958 to 10328 1 to 370       370/370
(100 %)
3 diff
(99.2 %id)
C15464   .b 9958 to 10207 1 to 249       249/249
(100 %)
1 diff
(99.6 %id)
H20999 brain .b 9973 to 10426 1 to 460       460/466
(98 %)
15 diff
(96.8 %id)
H45390 brain .b 9973 to 10487 2 to 517       516/517
(99 %)
6 diff
(98.9 %id)
BX117600 brain .b 9976 to 10683 1 to 708       708/708
(100 %)
6 diff
(99.2 %id)
DA120176 cerebellum .b 10008 to 10537 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BF964875 muscle (skeletal) .b 10022 to 10718 1 to 690       690/854
(80 %)
20 diff
(97.7 %id)
BU167694 leiomyosarcoma, uterus .b 10058 to 10941 1 to 891       891/899
(99 %)
18 diff
(98.0 %id)
BG566656 Liver .b 10079 to 11000 1 to 910       910/911
(99 %)
31 diff
(96.6 %id)
BU190027 leiomyosarcoma, uterus .b 10081 to 10959 1 to 884       884/885
(99 %)
10 diff
(98.9 %id)
BF215608 brain, glioblastoma .b 10096 to 10807 1 to 709       709/810
(87 %)
23 diff
(97.2 %id)
CD673720 eye, lens .b 10136 to 10688 1 to 553       553/553
(100 %)
0 diff
(100 %id)
AA058800 uterus .b 10153 to 10514 1 to 365   fully sequenced,   365/365
(100 %)
6 diff
(98.4 %id)
BF693476 muscle (skeletal) .b 10195 to 10851 1 to 637       637/664
(95 %)
26 diff
(96.1 %id)
TI_149302146   .b 10200 to 11053 922 to 83   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 840/964
(87 %)
21 diff
(97.9 %id)
BM698966 eye, fetal eyes .b 10202 to 10677 1 to 476   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 476/476
(100 %)
0 diff
(100 %id)
BG153437 carcinoid, lung .b 10231 to 10806 578 to 3       576/578
(99 %)
0 diff
(100 %id)
BE739372 hypernephroma, Kidney .b 10243 to 11005 761 to 1       761/761
(100 %)
11 diff
(98.6 %id)
AI268296 carcinoid, lung .b 10271 to 10811 542 to 2       541/542
(99 %)
0 diff
(100 %id)
TI_149314732   .b 10286 to 11053 836 to 79   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 758/935
(81 %)
26 diff
(97.3 %id)
BQ006402 Chondrosarcoma, Left Pelvis .b 10308 to 11049 757 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 741/741
(100 %)
4 diff
(99.5 %id)
CB850946 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 10328 to 11053 743 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 725/725
(100 %)
4 diff
(99.5 %id)
AW978552   .b 10337 to 11045 708 to 1     Submitted on the opposite strand 708/708
(100 %)
3 diff
(99.6 %id)
TI_149271691   .b 10340 to 11053 807 to 94   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 714/1020
(70 %)
2 diff
(99.9 %id)
BU674577 lung, Primary Lung Epithelial Cells .b 10340 to 11053 732 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 714/719
(99 %)
2 diff
(99.8 %id)
CK429401 eye, lacrimal gland .b 10354 to 10992 1 to 638       638/638
(100 %)
2 diff
(99.7 %id)
N47161 multiple sclerosis lesions .b 10368 to 10574 1 to 207       207/207
(100 %)
3 diff
(98.6 %id)
AA303034 uterus .b 10387 to 10749 1 to 361       361/361
(100 %)
3 diff
(99.2 %id)
BQ574298 Chondrosarcoma Grade II, Left Pelvis .b 10439 to 11047 634 to 25   AAA   610/616
(99 %)
0 diff
(100 %id)
CA867224 Pancreas, Purified pancreatic islet .b 10445 to 11047 610 to 8       603/610
(98 %)
0 diff
(100 %id)
CB134636 Liver .b 10458 to 11042 584 to 1     Submitted on the opposite strand 584/584
(100 %)
1 diff
(99.9 %id)
BF513610   .b 10473 to 11053 599 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 582/582
(100 %)
1 diff
(99.9 %id)
AA670255   .b 10483 to 10752 269 to 1       269/269
(100 %)
7 diff
(97.4 %id)
AA045204 uterus .b 10484 to 11047 557 to 1   fully sequenced,   557/557
(100 %)
5 diff
(99.2 %id)
BG150468 pooled germ cell tumors .b 10491 to 11048 567 to 7       561/567
(98 %)
0 diff
(100 %id)
BF590227 pooled .b 10494 to 11054 564 to 3       562/564
(99 %)
0 diff
(100 %id)
DB295642   .b 10495 to 11048 561 to 8       554/561
(98 %)
0 diff
(100 %id)
AI857636 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 10495 to 11054 566 to 7       560/566
(98 %)
0 diff
(100 %id)
DB352510 uterus .b 10497 to 11047 552 to 1       552/552
(100 %)
1 diff
(99.9 %id)
AI970101 pooled germ cell tumors .b 10498 to 11054 558 to 2       557/558
(99 %)
0 diff
(100 %id)
DB348405 trachea .b 10511 to 11053 542 to 1       542/542
(100 %)
2 diff
(99.7 %id)
AW007701 thymus, pooled .b 10513 to 11053 541 to 1       541/541
(100 %)
1 diff
(99.9 %id)
DB352159 uterus .b 10513 to 11053 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
CB306247 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 10517 to 11053 555 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 537/537
(100 %)
0 diff
(100 %id)
AI799478 pooled .b 10530 to 11041 522 to 12       511/522
(97 %)
0 diff
(100 %id)
AA521166 germinal center B cell .b 10537 to 11054 527 to 9       519/561
(92 %)
0 diff
(100 %id)
BF056355 pooled germ cell tumors .b 10572 to 11048 483 to 7       477/483
(98 %)
0 diff
(100 %id)
AA831155 germinal center B cell .b 10587 to 11046 472 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 459/459
(100 %)
1 diff
(99.8 %id)
DB516571 testis .b 10591 to 11053 1 to 462     Submitted on the opposite strand 462/462
(100 %)
1 diff
(99.8 %id)
AA243281 germinal center B cell .b 10591 to 11049 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AW197617 pooled germ cell tumors .b 10591 to 11053 473 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 463/463
(100 %)
0 diff
(100 %id)
AI582621 Kidney .b 10595 to 11053 458 to 1       458/458
(100 %)
3 diff
(99.4 %id)
AW020577 cochlea, ear .b 10599 to 11052 8 to 460   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 453/460
(98 %)
6 diff
(98.7 %id)
AI015124   .b 10603 to 11049 453 to 6       448/458
(97 %)
0 diff
(100 %id)
AI355156 esophagus, squamous cell carcinoma .b 10612 to 11053 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
AW664500 2 pooled high-grade transitional celltumors, genitourinary tract .b 10614 to 11054 441 to 1   tiling clone,   441/441
(100 %)
0 diff
(100 %id)
BU951467 Pancreas, Purified pancreatic islet .b 10614 to 11045 430 to 1       430/430
(100 %)
5 diff
(98.9 %id)
AW105025 pooled .b 10639 to 11054 419 to 4       416/419
(99 %)
0 diff
(100 %id)
AA132743 colon, tumor .b 10640 to 11054 425 to 4       422/427
(98 %)
0 diff
(100 %id)
BU737396 eye, fetal eyes .b 10647 to 11053 425 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 407/407
(100 %)
1 diff
(99.8 %id)
AA948581 pooled .b 10649 to 11053 418 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 405/405
(100 %)
1 diff
(99.8 %id)
N46842 multiple sclerosis lesions .b 10661 to 11047 391 to 1       391/392
(99 %)
13 diff
(96.7 %id)
AI473827 colon, moderately-differentiated adenocarcinoma .b 10663 to 11053 416 to 27   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 390/391
(99 %)
0 diff
(100 %id)
AW305073 brain, three pooled meningiomas .b 10663 to 11054 392 to 2       391/392
(99 %)
0 diff
(100 %id)
AA825892 germinal center B cell .b 10672 to 11053 396 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 382/382
(100 %)
3 diff
(99.3 %id)
D60796   .b 10702 to 11053 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
BF438967 pooled .b 10706 to 11052 346 to 1       346/346
(100 %)
1 diff
(99.8 %id)
AA303035 uterus .b 10745 to 11053 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
AI699856 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 10747 to 11054 312 to 2       311/312
(99 %)
0 diff
(100 %id)
H45391 brain .b 10758 to 11024 267 to 1       267/267
(100 %)
2 diff
(99.3 %id)
H20959 brain .b 10806 to 11049 244 to 1       244/255
(95 %)
2 diff
(99.3 %id)
AI566600 adenocarcinoma, Pancreas .b 10882 to 11047 196 to 31   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 166/167
(99 %)
0 diff
(100 %id)
BE218305 carcinoid, lung .c 1 to 460 462 to 1   tiling clone,   462/462
(100 %)
2 diff
(99.6 %id)
BF829790 head_normal .c 329 to 476 16 to 162   tiling clone,   147/162
(90 %)
6 diff
(96.3 %id)
BE327302 carcinoid, lung .c 426 to 887 467 to 6   tiling clone,   462/474
(97 %)
0 diff
(100 %id)
BF445221 carcinoid, lung .c 426 to 887 468 to 7       462/474
(97 %)
0 diff
(100 %id)
BE327299 carcinoid, lung .c 435 to 887 458 to 6       453/458
(98 %)
0 diff
(100 %id)
AI796862 carcinoid, lung .c 518 to 874 357 to 1       357/358
(99 %)
3 diff
(99.2 %id)
BF057363 fibrotheoma, ovary .c 558 to 1096 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
AW299388 Kidney .c 565 to 1096 532 to 1       532/532
(100 %)
6 diff
(98.9 %id)
AW149610 brain, medulloblastoma .c 598 to 1053 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
AW001856 thymus, pooled .c 616 to 1096 481 to 1   tiling clone,   481/481
(100 %)
3 diff
(99.4 %id)
AI745150 ovary, tumor, 5 pooled (see description) .c 637 to 1061 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AW058180 thymus, pooled .c 747 to 1061 316 to 1   tiling clone,   316/316
(100 %)
1 diff
(99.7 %id)
AW087711 pooled .c 747 to 1053 308 to 1       308/308
(100 %)
1 diff
(99.7 %id)
AI560467 anaplastic oligodendroglioma, brain .c 833 to 1061 230 to 1       230/230
(100 %)
1 diff
(99.6 %id)
DR000305 fetal brain .c 1073 to 1753 8 to 688   tiling clone,   681/688
(98 %)
11 diff
(98.5 %id)
AI760702 B-cell, chronic lymphotic leukemia .c 1089 to 1670 1 to 580   tiling clone, Submitted on the opposite strand 580/580
(100 %)
9 diff
(98.5 %id)
AW661804 pooled .c 1089 to 1494 1 to 402     Submitted on the opposite strand 402/402
(100 %)
11 diff
(97.3 %id)
AW444965   .c 1090 to 1470 1 to 381     Submitted on the opposite strand 381/391
(97 %)
4 diff
(99.0 %id)
DB452396 testis .c 1521 to 1995 1 to 475 exact tiling clone,   475/475
(100 %)
0 diff
(100 %id)
BX490863   .d 1 to 444 1 to 454 exact tiling clone,   454/454
(100 %)
11 diff
(97.6 %id)
DB229423 trachea .e-u 1 to 549 2 to 550 exact tiling clone, to resequence, capped   549/549
(100 %)
1 diff
(99.9 %id)
DB145653 thymus .e-u 16 to 552 2 to 538 exact tiling clone, capped   537/537
(100 %)
2 diff
(99.7 %id)
N42407 melanocyte .e-u 1257 to 1679 1 to 423   tiling clone,   423/424
(99 %)
3 diff
(99.3 %id)
DB232090 trachea .e-u 1301 to 1817 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
BX480579   .e-u 1340 to 1840 1 to 498       498/498
(100 %)
14 diff
(97.2 %id)
AL708624 human skeletal muscle .e-u 1379 to 1902 1 to 524   tiling clone,   524/524
(100 %)
1 diff
(99.9 %id)
R59013 whole brain .e-u 1463 to 1952 1 to 492   tiling clone, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 492/495
(99 %)
4 diff
(99.2 %id)
DA817276   .e-u 1952 to 2528 2 to 578   tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
R65864 placenta .e-u 1973 to 2306 1 to 344       344/362
(95 %)
10 diff
(97.3 %id)
DA308027 hippocampus .e-u 2000 to 2565 2 to 567   capped   566/567
(99 %)
1 diff
(99.9 %id)
BI259570 cervical carcinoma cell line, cervix .e-u 2100 to 2652 156 to 710       555/736
(75 %)
6 diff
(99.2 %id)
DA974225 synovial membrane tissue from rheumatioidarthritis .e-u 2113 to 2696 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
ES312239 frontal balding hair, skin .e-u 2136 to 2299 1 to 164       164/164
(100 %)
0 diff
(100 %id)
BF575560 muscle (skeletal) .e-u 2215 to 2944 1 to 722       722/725
(99 %)
18 diff
(97.6 %id)
C01448   .e-u 2220 to 2554 1 to 337       337/340
(99 %)
9 diff
(97.4 %id)
BE176389 head_neck .e-u 2230 to 2881 652 to 1     Submitted on the opposite strand 652/652
(100 %)
12 diff
(98.2 %id)
BQ356583 head_neck .e-u 2242 to 2662 1 to 421       421/432
(97 %)
13 diff
(97.0 %id)
BE173670 head_neck .e-u 2252 to 2678 1 to 427       427/427
(100 %)
7 diff
(98.4 %id)
DB451071 testis .e-u 2267 to 2715 1 to 451       451/453
(99 %)
8 diff
(98.3 %id)
BE090738 breast .e-u 2349 to 2661 22 to 333       312/333
(93 %)
7 diff
(97.9 %id)
TI_149302150   .e-u 2445 to 3258 887 to 88   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 800/929
(86 %)
71 diff
(92.4 %id)
BE973756 Prostate .e-u 2487 to 3018 1 to 530   tiling clone,   530/533
(99 %)
7 diff
(98.7 %id)
FN099682 breast carcinoma .e-u 2505 to 2594 91 to 3     Submitted on the opposite strand 89/99
(89 %)
0 diff
(100 %id)
CA432626 cell lines, Chondrosarcoma .e-u 2583 to 3253 689 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 671/671
(100 %)
2 diff
(99.8 %id)
BQ220230 embryonal carcinoma, cell line, testis .e-u 2595 to 3174 1 to 583       583/1022
(57 %)
17 diff
(98.4 %id)
DB349917 trachea .e-u 2624 to 3170 547 to 1   tiling clone, to resequence,   547/547
(100 %)
0 diff
(100 %id)
BQ434186 embryonal carcinoma, cell line, testis .e-u 2688 to 3174 1 to 490       490/1024
(47 %)
30 diff
(97.1 %id)
DA373041 thalamus .e-u 2715 to 3344 2 to 632   capped   631/631
(100 %)
1 diff
(99.9 %id)
AV661338 corresponding non cancerous liver tissue .e-u 2732 to 3125 10 to 403     Submitted on the opposite strand 394/403
(97 %)
5 diff
(98.8 %id)
N33431 melanocyte .e-u 2760 to 3170 413 to 1       413/413
(100 %)
6 diff
(98.6 %id)
N51282 multiple sclerosis lesions .e-u 2760 to 3253 498 to 1       498/498
(100 %)
5 diff
(99.0 %id)
BQ002390 Chondrosarcoma, Left Pelvis .e-u 2762 to 3253 509 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 491/491
(100 %)
7 diff
(98.6 %id)
AW241634 Kidney .e-u 2770 to 3258 489 to 1       489/489
(100 %)
0 diff
(100 %id)
N50665 multiple sclerosis lesions .e-u 2795 to 3254 471 to 1       471/497
(94 %)
13 diff
(97.4 %id)
AI765777 2 pooled tumors (clear cell type), Kidney .e-u 2795 to 3259 469 to 5       465/469
(99 %)
0 diff
(100 %id)
AA406134 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e-u 2802 to 3173 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
BE245691 leukopheresis .e-u 2811 to 3255 478 to 34       445/478
(93 %)
0 diff
(100 %id)
R58959 whole brain .e-u 2829 to 3258 454 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 439/439
(100 %)
14 diff
(96.9 %id)
AA724716 pooled .e-u 2830 to 3176 355 to 9       347/355
(97 %)
0 diff
(100 %id)
FN090832 breast carcinoma .e-u 2855 to 2915 1 to 60       60/61
(98 %)
2 diff
(96.8 %id)
BM452891 melanotic melanoma, skin .e-u 2857 to 3640 35 to 827   tiling clone,   793/970
(81 %)
12 diff
(98.8 %id)
BU955417 mixed (pool of 40 RNAs) .e-u 2876 to 3257 1 to 382       382/419
(91 %)
2 diff
(99.6 %id)
D62120   .e-u 2881 to 3247 1 to 380       380/380
(100 %)
14 diff
(96.4 %id)
AW076123 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .e-u 2882 to 3259 380 to 2       379/380
(99 %)
0 diff
(100 %id)
AW008728 brain, glioblastoma (pooled) .e-u 2899 to 3253 355 to 1       355/355
(100 %)
0 diff
(100 %id)
AI493824 Kidney .e-u 2927 to 3258 332 to 1       332/332
(100 %)
0 diff
(100 %id)
AL040539 testis .e-u 2931 to 3275 1 to 345       345/345
(100 %)
1 diff
(99.8 %id)
AA828446 germinal center B cell .e-u 2935 to 3258 335 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 324/324
(100 %)
0 diff
(100 %id)
FN139404 breast carcinoma .e-u 2936 to 3044 104 to 1     Submitted on the opposite strand 104/108
(96 %)
5 diff
(95.4 %id)
R65773 placenta .e-u 2939 to 3258 329 to 1       329/331
(99 %)
17 diff
(94.9 %id)
AI288153 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e-u 2955 to 3253 313 to 15   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 299/299
(100 %)
0 diff
(100 %id)
DB016141 esophageal, tumor tissue .e-u 2980 to 3550 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AI446093 adenocarcinoma, Pancreas .e-u 3013 to 3255 244 to 2       243/244
(99 %)
0 diff
(100 %id)
DA602057   .e-u 3017 to 3572 2 to 558   tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
BF678184 Prostate .f-u 1 to 377 1 to 381   tiling clone, available from MGC,   381/442
(86 %)
19 diff
(95.8 %id)
BC017814 Prostate .f-u 2 to 403 1 to 401   tiling clone, available from MGC, AAA   401/401
(100 %)
1 diff
(99.8 %id)
AF234262   .f-u 376 to 1922 1 to 1559 L78I F79L S80F C81S L82C ... tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 1559/1560
(99 %)
10 diff
(99.4 %id)
BQ360779 ovary .f-u 898 to 1276 377 to 4   tiling clone,   374/379
(98 %)
0 diff
(100 %id)
BX280214 Prostate .f-u 1447 to 1923 1 to 477   tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 477/477
(100 %)
0 diff
(100 %id)
BI033758 nervous_normal .g-u 1 to 181 18 to 198   tiling clone,   181/198
(91 %)
9 diff
(95.5 %id)
BM727830 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g-u 85 to 521 1 to 437 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 437/437
(100 %)
0 diff
(100 %id)
BE159560 head_neck .g-u 156 to 320 175 to 12     Submitted on the opposite strand 164/197
(83 %)
0 diff
(100 %id)
BF436580 fibrotheoma, ovary .g-u 266 to 519 255 to 2       254/255
(99 %)
0 diff
(100 %id)
BQ365136 placenta_normal .h-u 1 to 226 229 to 4 exact tiling clone,   226/229
(98 %)
0 diff
(100 %id)
AV714985   Gene MAP3K2, variant not shown         Suspected internal deletion, this clone was ignored    
AL599344   Gene MAP3K2, variant not shown         Suspected internal deletion, this clone was ignored    
AV655054 corresponding non cancerous liver tissue Gene MAP3K2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f-u, .g-u, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI